Adsorption of immunopotentiators to insoluble metal salts
Immunopotentiators can be adsorbed to insoluble metal salts, such as aluminum salts, to modify their pharmacokinetics, pharmacodynamics, intramuscular retention time, and/or immunostimulatory effect. Immunopotentiators are modified to introduce a moiety, such as a phosphonate group, which can mediate adsorption. These modified compounds can retain or improve their in vivo immunological activity even when delivered in an adsorbed form.
Novartis AG
A A A A C A A A Y C C A C A A C A A A A A C A A C A
A61K A61P A61K A61P C07F A61K A61K A61K Y02A C07D C07D A61P C07F A61K A61K C07F A61K A61K A61K A61K A61K C07F A61P A61K C07F A61K
inventional inventional inventional inventional inventional inventional inventional inventional additional inventional inventional inventional inventional additional inventional inventional inventional inventional inventional inventional additional inventional inventional inventional inventional inventional
Timothy Z. David A. G. Jianfeng Tom Yao-Hsiang Kathy Yefen Yongkai Xiaoyue Alex Manmohan
Hoffman Skibinski Pan Wu Yue Zou Li Zhang Cortez Singh